<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="66afab92-2ef3-4f89-8057-3cfd6e69a1d8"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Nelson Mandela — True-date frame: synthetic events are moved into the patient&apos;s historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.</title>
  <effectiveTime value="20010714120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="0575dd30-4395-46d7-afbe-6f42aec75e14"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="61084987-1713-4db4-8572-02db649c0d0a" extension="HR-ML021-SYN-TD"/>
      <id root="2.16.840.1.113883.4.1" extension="000-21-6718"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Nelson</given><family>Mandela</family></name>
        <administrativeGenderCode code="M" codeSystem="2.16.840.1.113883.5.1" displayName="Male"/>
        <birthTime value="19180718"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20010714120000-0500"/>
    <assignedAuthor><id root="c4d853ba-3778-46ad-94f3-23f7de881159"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Thandiwe</given><family>Mokoena</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20010714120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="c4d853ba-3778-46ad-94f3-23f7de881159"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Thandiwe</given><family>Mokoena</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20010714"/><high value="20010714"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="c4d853ba-3778-46ad-94f3-23f7de881159"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Thandiwe</given><family>Mokoena</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="afdf3d14-4cbd-49ab-a13e-0f5a1057db72"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Three-month follow-up on androgen deprivation before radiotherapy: PSA, testosterone, vitamin D, and side effects</originalText></code>
      <effectiveTime><low value="20010714"/><high value="20010714"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="c4d853ba-3778-46ad-94f3-23f7de881159"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Thandiwe</given><family>Mokoena</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Three-month follow-up on androgen deprivation, ten days before radiotherapy. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mr. Mandela returns three months after his last visit, twelve weeks after his first leuprolide injection. He completed four weeks of bicalutamide. Hot flashes continue three or four times a week and are mild; his energy is a little lower in the afternoons, and he still walks every morning. His weight is up 1.2 kg since starting treatment. He has had no breast tenderness, chest pain, breathlessness, or leg swelling, and his mood and memory are unchanged. Fiducial markers were placed and the planning scans done a week ago, without complications. Radiotherapy starts in ten days. Urinary symptoms are unchanged. The audiology test after his wellness visit showed mild high-frequency hearing loss on the left, and he is thinking about a hearing aid. He takes vitamin D every day. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Androgen deprivation</td><td>Twelve weeks on leuprolide; second injection given today</td></tr><tr><td>Side effects</td><td>Mild hot flashes; slightly lower afternoon energy; weight up 1.2 kg</td></tr><tr><td>Radiotherapy</td><td>Fiducial markers placed and planning done; treatment starts in ten days</td></tr><tr><td>Hearing</td><td>Mild high-frequency loss on the left on audiology</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Positive</td><td>Slightly lower afternoon energy; weight up 1.2 kg</td></tr><tr><td>Endocrine</td><td>Positive</td><td>Mild hot flashes three or four times a week; no breast tenderness</td></tr><tr><td>Cardiovascular</td><td>Negative</td><td>No chest pain or leg swelling</td></tr><tr><td>Genitourinary</td><td>Positive</td><td>Mild urinary frequency, unchanged; no blood in the urine</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Mood good; PHQ-2 score 1; no change in memory</td></tr></tbody></table><paragraph>5 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Bicalutamide 50 mg oral tablet, one tablet by mouth once daily for four weeks, to block the testosterone flare at the start of leuprolide</td><td>One tablet once daily for four weeks</td><td>Oral route</td><td>2001-04-14 to 2001-05-12</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Leuprolide acetate 22.5 mg injection (three-month depot), intramuscular, two doses twelve weeks apart (the second given at a primary care visit), about six months of androgen deprivation with radiotherapy</td><td>One injection every twelve weeks, two doses</td><td>Intramuscular route</td><td>2001-04-21 to 2001-10-06</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once daily</td><td>One tablet once daily</td><td>Oral route</td><td>2001-04-14</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="aa70f948-acf2-436c-9d1d-08e765ced7b7"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20010414"/><high value="20010512"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="199123" codeSystem="2.16.840.1.113883.6.88" displayName="bicalutamide 50 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="99b85595-50de-460f-93d3-a3a5a2c50938"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C61" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of prostate"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="7834d13a-3bea-4942-8ccb-88ab05621c4f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.899" codeSystem="2.16.840.1.113883.6.90" displayName="Other long term (current) drug therapy"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="ffe78436-723f-41d9-8a73-917d5aed11a1"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20010421"/><high value="20011006"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="12" unit="wk"/></effectiveTime>
      <routeCode code="C28161" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Intramuscular route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="2606516" codeSystem="2.16.840.1.113883.6.88" displayName="leuprolide acetate 22.5 MG Injection"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="25b331ec-18e6-4bef-a2d0-17740086d009"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="C61" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of prostate"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="b7cf593e-433f-44bf-a727-baea78dad0a4"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.899" codeSystem="2.16.840.1.113883.6.90" displayName="Other long term (current) drug therapy"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="a32c69cf-9012-43ec-8754-abf2c838f9c0"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20010414"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="199362" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.025 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="3510a053-f557-4cb5-b4fc-7cab2aaff619"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="Z79.899" codeSystem="2.16.840.1.113883.6.90" displayName="Other long term (current) drug therapy"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="f0634d68-84e9-40bb-b629-e60695addf8f"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20010310"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="68624d75-85d9-4b35-b1d6-e417b7d1d465"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-3-1"><td>2001-07-14</td><td>Body height</td><td>183</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-3-2"><td>2001-07-14</td><td>Body weight</td><td>81.6</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-3-3"><td>2001-07-14</td><td>Body mass index (BMI) [Ratio]</td><td>24.4</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-3-4"><td>2001-07-14</td><td>Systolic blood pressure</td><td>134</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-5"><td>2001-07-14</td><td>Diastolic blood pressure</td><td>78</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-6"><td>2001-07-14</td><td>Heart rate</td><td>70</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-7"><td>2001-07-14</td><td>Respiratory rate</td><td>14</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-8"><td>2001-07-14</td><td>Body temperature</td><td>36.6</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-3-9"><td>2001-07-14</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>97</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="cf070fa6-6657-4d94-8918-827e0f33721f"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20010714"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="15061e62-12f4-428c-86fd-9499c4e2e116"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-3-1"/></text><statusCode code="completed"/><effectiveTime value="20010714"/><value xsi:type="PQ" value="183" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="a62e836b-214a-4e1c-982a-516135b040f5"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-3-2"/></text><statusCode code="completed"/><effectiveTime value="20010714"/><value xsi:type="PQ" value="81.6" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="4140c38b-f258-416d-b8ab-dcb7ea54a610"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-3-3"/></text><statusCode code="completed"/><effectiveTime value="20010714"/><value xsi:type="PQ" value="24.4" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="1a8917c1-956d-49f5-aa65-9f2ec1fdaa12"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-3-4"/></text><statusCode code="completed"/><effectiveTime value="20010714"/><value xsi:type="PQ" value="134" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="d08a847f-9c71-418b-be80-3dcd3f8f3e6e"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-3-5"/></text><statusCode code="completed"/><effectiveTime value="20010714"/><value xsi:type="PQ" value="78" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="8310a1a5-7814-4608-9173-e96fc5b5c7b9"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-3-6"/></text><statusCode code="completed"/><effectiveTime value="20010714"/><value xsi:type="PQ" value="70" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="5a177b36-bd44-46a1-8348-2d6b278840e1"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-3-7"/></text><statusCode code="completed"/><effectiveTime value="20010714"/><value xsi:type="PQ" value="14" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="0daf6e19-c526-44c5-921c-b9616531152a"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-3-8"/></text><statusCode code="completed"/><effectiveTime value="20010714"/><value xsi:type="PQ" value="36.6" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="24174743-bbc2-41ed-9413-8fab0be5470f"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-3-9"/></text><statusCode code="completed"/><effectiveTime value="20010714"/><value xsi:type="PQ" value="97" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-26"><td>2001-07-14</td><td>Prostate specific Ag [Mass/volume] in Serum or Plasma</td><td>0.9</td><td>ng/mL</td><td>&lt;=4 ng/mL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-27"><td>2001-07-14</td><td>Testosterone [Mass/volume] in Serum or Plasma</td><td>18</td><td>ng/dL</td><td>264 to 916 ng/dL in adult men; below 50 ng/dL is the castrate target on androgen deprivation</td><td>Low</td><td>S</td></tr>
  <tr ID="result-28"><td>2001-07-14</td><td>25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma</td><td>34</td><td>ng/mL</td><td>30-100 ng/mL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-29"><td>2001-07-14</td><td>Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]</td><td>1</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="60b01cc8-37ac-4e16-84e6-d5078effd795"/>
      <code code="2857-1" codeSystem="2.16.840.1.113883.6.1" displayName="Prostate specific Ag [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20010714"/><high value="20010714"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="b36d763f-c09a-4606-a55c-4a48812792f3"/>
          <code code="2857-1" codeSystem="2.16.840.1.113883.6.1" displayName="Prostate specific Ag [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-26"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20010714"/>
          <value xsi:type="PQ" value="0.9" unit="ng/mL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>&lt;=4 ng/mL</text>
              <value xsi:type="IVL_PQ"><high value="4" unit="ng/mL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="81cba64f-1063-4db4-91da-4619afc9dbbf"/>
      <code code="2986-8" codeSystem="2.16.840.1.113883.6.1" displayName="Testosterone [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20010714"/><high value="20010714"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="79c0ed90-3fd7-4dc5-a166-d57172a0afc9"/>
          <code code="2986-8" codeSystem="2.16.840.1.113883.6.1" displayName="Testosterone [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-27"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20010714"/>
          <value xsi:type="PQ" value="18" unit="ng/dL"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>264 to 916 ng/dL in adult men; below 50 ng/dL is the castrate target on androgen deprivation</text>
              <value xsi:type="IVL_PQ"><low value="264" unit="ng/dL"/><high value="916" unit="ng/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="55c247f9-860a-4811-925e-fba4ef79df11"/>
      <code code="62292-8" codeSystem="2.16.840.1.113883.6.1" displayName="25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20010714"/><high value="20010714"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="b7f36963-2447-4657-9d97-2493d82297c4"/>
          <code code="62292-8" codeSystem="2.16.840.1.113883.6.1" displayName="25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-28"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20010714"/>
          <value xsi:type="PQ" value="34" unit="ng/mL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>30-100 ng/mL</text>
              <value xsi:type="IVL_PQ"><low value="30" unit="ng/mL"/><high value="100" unit="ng/mL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="92a8ab51-7e4f-4d2a-8558-12569e7a0539"/>
      <code code="55758-7" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20010714"/><high value="20010714"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="62752866-4bbb-4fb7-876a-caf0d8d827cf"/>
          <code code="55758-7" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]"/>
          <text><reference value="#result-29"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20010714"/>
          <value xsi:type="PQ" value="1" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2001-07-14; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well</td></tr><tr><td>Cardiovascular</td><td>Regular rhythm; blood pressure 134/78 mm Hg; no ankle swelling</td></tr><tr><td>Chest</td><td>No gynecomastia</td></tr><tr><td>Perineum</td><td>Fiducial insertion sites healed</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Adenocarcinoma of the prostate, NCCN unfavorable intermediate risk: cT1c, Grade Group 3 (Gleason 4+3), PSA 6.4 ng/mL, 3 of 14 cores, found after a rising PSA; synthetic modern detail linked to his publicly announced prostate cancer</td><td>active</td><td>confirmed</td>
    <td>C61</td><td>S — Synthetic grade, PSA, core count, stage, and risk group; the PSA rise, the biopsy-proven localized cancer that was not high grade, hormone therapy, and curative radiotherapy are from his doctors&apos; and spokeswoman&apos;s public statements (D).</td>
  </tr>
  <tr ID="problem-2">
    <td>Hormone-sensitive prostate cancer</td><td>active</td><td>confirmed</td>
    <td>Z19.1</td><td>S — Synthetic status in the modern episode.</td>
  </tr>
  <tr ID="problem-3">
    <td>Short-term androgen deprivation therapy (six months, leuprolide), with monitoring of testosterone, bone density, metabolic and cardiovascular risk, hot flashes, mood, and cognition</td><td>active</td><td>confirmed</td>
    <td>Z79.899</td><td>S — Synthetic androgen deprivation plan; Z79.899 is used because ICD-10-CM has no specific code for GnRH agonist therapy.</td>
  </tr>
  <tr ID="problem-4">
    <td>History of pulmonary tuberculosis, treated, with no symptoms since</td><td>resolved</td><td>confirmed</td>
    <td>Z86.11</td><td>S — The 1988 tuberculosis is documented (D); the coding and the statement that it has not recurred are synthetic.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="f580d6cf-d9bf-4ea0-9f06-be088ebe8019"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20010310"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c28d8e54-f1f1-4292-9bd9-22432c39281e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20010310"/></effectiveTime>
          <value xsi:type="CD" code="C61" codeSystem="2.16.840.1.113883.6.90" displayName="Malignant neoplasm of prostate"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="16adb80a-2696-4a7f-8605-05bd7fb89e5f"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20010310"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="dfac41d8-4a7a-4929-9332-96e8e31aa8c7"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20010310"/></effectiveTime>
          <value xsi:type="CD" code="Z19.1" codeSystem="2.16.840.1.113883.6.90" displayName="Hormone sensitive malignancy status"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="37d0b777-e4df-428c-b79f-d7c2a24d1607"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20010414"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="36b380fb-124d-45b9-ac43-f4aa8fb2c60c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20010414"/></effectiveTime>
          <value xsi:type="CD" code="Z79.899" codeSystem="2.16.840.1.113883.6.90" displayName="Other long term (current) drug therapy"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="b24d7f5d-69a5-4773-b8e7-f6116dd7a6ca"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20010310"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="e5fe3391-dc62-4108-a6f2-0d29ebe3b68a"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20010310"/></effectiveTime>
          <value xsi:type="CD" code="Z86.11" codeSystem="2.16.840.1.113883.6.90" displayName="Personal history of tuberculosis"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Prostate cancer, unfavorable intermediate risk, on androgen deprivation before radiotherapy (C61)</content>. PSA has fallen from 6.4 to 0.9 ng/mL on androgen deprivation, as expected. [S]<list><item>Radiotherapy, 74 Gy in 37 fractions, starts in ten days.</item><item>Report urinary burning, frequency, or bowel urgency during treatment to radiation oncology.</item></list></item><item><content styleCode="Bold">Androgen deprivation therapy (Z79.899)</content>. Testosterone 18 ng/dL, at the castrate target. Mild hot flashes and fatigue; weight up 1.2 kg; blood pressure 134/78 mm Hg. Vitamin D is now 34 ng/mL. [S]<list><item>Second leuprolide 22.5 mg injection given today; this completes the six-month course.</item><item>Continue cholecalciferol 1000 units daily.</item><item>Keep walking and resistance exercise for fatigue, weight, and bone.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Laboratory</td><td>PSA on androgen deprivation</td><td>Every 3 to 6 months</td><td>Completed today</td><td>0.9 ng/mL, down from 6.4</td></tr><tr><td>Laboratory</td><td>Testosterone</td><td>Every 3 to 6 months on androgen deprivation (target below 50 ng/dL)</td><td>Completed today</td><td>18 ng/dL, castrate</td></tr><tr><td>Laboratory</td><td>25-hydroxyvitamin D</td><td>Three months after starting a supplement</td><td>Completed today</td><td>34 ng/mL, up from 26</td></tr><tr><td>Laboratory</td><td>Hemoglobin A1c or fasting glucose, and lipid panel</td><td>Baseline and yearly on androgen deprivation</td><td>Up to date</td><td>Baseline four months ago; next in eight months</td></tr><tr><td>Imaging</td><td>Bone density (DXA)</td><td>Every 1 to 2 years on androgen deprivation</td><td>Up to date</td><td>Baseline three months ago</td></tr><tr><td>Examination</td><td>Blood pressure, weight, and cardiovascular assessment</td><td>Every visit on androgen deprivation</td><td>Completed today</td><td>134/78 mm Hg; weight 81.6 kg, up 1.2 kg since starting; no cardiac symptoms</td></tr><tr><td>Medication safety</td><td>Hot flashes and fatigue</td><td>Every visit on androgen deprivation</td><td>Completed today</td><td>Mild hot flashes three or four times a week; mild afternoon fatigue; no treatment wanted</td></tr><tr><td>Survey</td><td>Distress and depression screen (PHQ-2)</td><td>At intervals</td><td>Completed today</td><td>PHQ-2 score 1</td></tr><tr><td>Survey</td><td>Cognition</td><td>Periodically on androgen deprivation</td><td>Up to date</td><td>Mini-Cog 5 of 5 at the wellness visit five weeks ago; no change reported</td></tr><tr><td>Survey</td><td>Urinary symptoms</td><td>Before radiotherapy, then every follow-up visit</td><td>Completed today</td><td>Mild frequency, unchanged from the baseline IPSS of 7</td></tr><tr><td>Survey</td><td>Bowel function before radiotherapy</td><td>Baseline before radiotherapy, then every visit after it</td><td>Deferred</td><td>Not asked today, a deviation from the protocol; the visit was taken up by the androgen deprivation results and the radiotherapy plan. To be checked at the next visit</td></tr><tr><td>Medication safety</td><td>Second leuprolide injection</td><td>Every twelve weeks for two doses</td><td>Completed today</td><td>Given today in this clinic</td></tr><tr><td>Self-management</td><td>Physical activity and calcium intake</td><td>Every visit</td><td>Completed today</td><td>Walking every morning; resistance exercise twice a week; calcium from food</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Reach an informed, shared decision on treatment after hearing every reasonable option, including observation. Outcome by 2001-04-14: Radiotherapy with six months of androgen deprivation chosen at the radiation oncology consultation [S]</item><item>Complete six months of androgen deprivation and the course of radiotherapy with side effects managed. In progress; target 2001-10-27 [S]</item><item>Protect bone health on androgen deprivation: baseline DXA, vitamin D of 30 ng/mL or more, dietary calcium, and weight-bearing exercise. Outcome by 2001-07-14: Femoral neck T-score -1.4; vitamin D 34 ng/mL on supplementation; walking daily [S]</item><item>PSA falling after radiotherapy, with a written surveillance plan. In progress; target 2001-10-27 [S]</item></list><paragraph>Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer (2026); Eastham JA, et al. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part III: Principles of Radiation and Future Directions. J Urol 2022;208(1):26-33 (2022); Skolarus TA, et al. American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin 2014;64(4):225-249 (2014); CMID: Clinical Monitoring Intelligence Database, prostate cancer monograph (2026)</paragraph><paragraph>Follow-up: Radiotherapy from ten days&apos; time, with weekly radiation oncology review. Primary care follow-up six weeks after radiotherapy ends, with PSA and testosterone. Next scheduled visit 2001-10-27: follow-up six weeks after radiotherapy: PSA, urinary and bowel effects, end of androgen deprivation, and the surveillance plan. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
